News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis Corporation (NVS) and Speedel Pharmaceuticals, Inc. at Loggerheads Over Tekturna Royalties



11/16/2007 12:40:40 PM

15 November 2007 -- Speedel has had a major falling-out with its fellow Swiss, but much bigger, partner Novartis over monies that the former believes it is owed relating to the new antihypertensive Tekturna/Rasilez.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES